首页> 美国卫生研究院文献>Advanced Science >ICAM‐1 Activates Platelets and Promotes Endothelial Permeability through VE‐Cadherin after Insufficient Radiofrequency Ablation
【2h】

ICAM‐1 Activates Platelets and Promotes Endothelial Permeability through VE‐Cadherin after Insufficient Radiofrequency Ablation

机译:ICAM-1在不足的射频消融后通过Ve-Cadherin激活血小板并促进内皮渗透性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) often leads to aggressive local recurrence and increased metastasis, and vascular integrity and platelets are implicated in tumor metastasis. However, whether interactions between endothelial cells and platelets induce endothelial permeability in HCC after insufficient RFA remains unclear. Here, significantly increased CD62P‐positive platelets and sP‐selectin in plasma are observed in HCC patients after RFA, and tumor‐associated endothelial cells (TAECs) activate platelets and are susceptible to permeability after heat treatment in the presence of platelets in vitro. In addition, tumors exhibit enhanced vascular permeability after insufficient RFA in mice; heat treatment promotes platelets‐induced endothelial permeability through vascular endothelial (VE)‐cadherin, and ICAM‐1 upregulation in TAECs after heat treatment results in platelet activation and increased endothelial permeability in vitro. Moreover, the binding interaction between upregulated ICAM‐1 and Ezrin downregulates VE‐cadherin expression. Furthermore, platelet depletion or ICAM‐1 inhibition suppresses tumor growth and metastasis after insufficient RFA in an orthotopic tumor mouse model, and vascular permeability decreases in ICAM‐1−/− mouse tumor after insufficient RFA. The findings suggest that ICAM‐1 activates platelets and promotes endothelial permeability in TAECs through VE‐cadherin after insufficient RFA, and anti‐platelet and anti‐ICAM‐1 therapy can be used to prevent progression of HCC after insufficient RFA.
机译:用于肝细胞癌(HCC)的射频消融(RFA)通常导致积极的局部复发和增加的转移,并且血管完整性和血小板涉及肿瘤转移。然而,在内皮细胞和血小板之间的相互作用是在不充分的RFA仍然不清楚后诱导HCC中的内皮渗透性。这里,在RFA之后在HCC患者中显着增加了血浆中的CD62P阳性血小板和SP-SELICIN,以及肿瘤相关的内皮细胞(TAECS)活化血小板,并且在体外存在血小板的热处理后易渗透性。此外,肿瘤在小鼠中不足后表现出增强的血管渗透性;热处理通过血管内皮(Ve) - 递质诱导血小板诱导的内皮渗透性,并且在热处理后TAECS中的ICAM-1上调导致血小板活化并增加体外内皮渗透性。此外,上调ICAM-1和Ezrin之间的结合相互作用下调了Ve-Cadherin表达。此外,血小板耗尽或ICAM-1抑制抑制在原位肿瘤小鼠模型中的RFA不足后抑制肿瘤生长和转移,并且RFA不足后ICAM-1 / - 小鼠肿瘤的血管渗透率降低。结果表明,在RFA不足之后,ICAM-1通过VE-Cadherin促进TAECS中的内皮渗透性,并且可以使用抗血小板和抗ICAM-1治疗来防止RFA不足后HCC进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号